High endothelial venules are associated with microsatellite instability, hereditary background and immune evasion in colorectal cancer.

Saved in:
Bibliographic Details
Title: High endothelial venules are associated with microsatellite instability, hereditary background and immune evasion in colorectal cancer.
Authors: Pfuderer PL; Department of Applied Tumour Biology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.; Clinical Cooperation Unit Applied Tumour Biology, DKFZ, Heidelberg, Germany.; Molecular Medicine Partnership Unit (MMPU), University Hospital Heidelberg, Heidelberg, Germany., Ballhausen A; Department of Applied Tumour Biology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.; Clinical Cooperation Unit Applied Tumour Biology, DKFZ, Heidelberg, Germany.; Molecular Medicine Partnership Unit (MMPU), University Hospital Heidelberg, Heidelberg, Germany., Seidler F; Department of Applied Tumour Biology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.; Clinical Cooperation Unit Applied Tumour Biology, DKFZ, Heidelberg, Germany.; Molecular Medicine Partnership Unit (MMPU), University Hospital Heidelberg, Heidelberg, Germany., Stark HJ; Department of Applied Tumour Biology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.; Clinical Cooperation Unit Applied Tumour Biology, DKFZ, Heidelberg, Germany.; Molecular Medicine Partnership Unit (MMPU), University Hospital Heidelberg, Heidelberg, Germany., Grabe N; Hamamatsu Tissue Imaging and Analysis (TIGA) Center, Heidelberg, Germany.; Department of Medical Oncology, National Center for Tumour Diseases (NCT), Heidelberg, Germany., Frayling IM; Inherited Tumour Syndromes Research Group, Institute of Cancer & Genetics, Cardiff University School of Medicine, Cardiff, UK., Ager A; Division of Infection and Immunity, School of Medicine and Systems Immunity Research Institute, Cardiff University, Cardiff, UK., von Knebel Doeberitz M; Department of Applied Tumour Biology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.; Clinical Cooperation Unit Applied Tumour Biology, DKFZ, Heidelberg, Germany.; Molecular Medicine Partnership Unit (MMPU), University Hospital Heidelberg, Heidelberg, Germany., Kloor M; Department of Applied Tumour Biology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.; Clinical Cooperation Unit Applied Tumour Biology, DKFZ, Heidelberg, Germany.; Molecular Medicine Partnership Unit (MMPU), University Hospital Heidelberg, Heidelberg, Germany., Ahadova A; Department of Applied Tumour Biology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany. aysel.ahadova@med.uni-heidelberg.de.; Clinical Cooperation Unit Applied Tumour Biology, DKFZ, Heidelberg, Germany. aysel.ahadova@med.uni-heidelberg.de.; Molecular Medicine Partnership Unit (MMPU), University Hospital Heidelberg, Heidelberg, Germany. aysel.ahadova@med.uni-heidelberg.de.
Source: British journal of cancer [Br J Cancer] 2019 Aug; Vol. 121 (5), pp. 395-404. Date of Electronic Publication: 2019 Jul 30.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1532-1827
DOI:10.1038/s41416-019-0514-6